"Influenza Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains.
Descriptor ID |
D007252
|
MeSH Number(s) |
D20.215.894.899.302
|
Concept/Terms |
Influenza Vaccines- Influenza Vaccines
- Influenza Vaccine
- Vaccine, Influenza
- Flu Vaccines
- Influenzavirus Vaccines
- Influenza Virus Vaccines
- Influenza Virus Vaccine
- Vaccine, Influenza Virus
- Virus Vaccine, Influenza
|
Below are MeSH descriptors whose meaning is more general than "Influenza Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Influenza Vaccines".
This graph shows the total number of publications written about "Influenza Vaccines" by people in this website by year, and whether "Influenza Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2002 | 3 | 0 | 3 |
2003 | 1 | 1 | 2 |
2004 | 3 | 2 | 5 |
2005 | 1 | 0 | 1 |
2006 | 3 | 0 | 3 |
2007 | 1 | 0 | 1 |
2008 | 3 | 0 | 3 |
2009 | 6 | 4 | 10 |
2010 | 5 | 0 | 5 |
2011 | 10 | 1 | 11 |
2012 | 7 | 0 | 7 |
2013 | 12 | 1 | 13 |
2014 | 5 | 3 | 8 |
2015 | 4 | 1 | 5 |
2016 | 12 | 1 | 13 |
2017 | 234 | 53 | 287 |
2018 | 219 | 35 | 254 |
2019 | 116 | 26 | 142 |
2020 | 48 | 13 | 61 |
2021 | 51 | 17 | 68 |
To return to the timeline, click here.
Below are the most recent publications written about "Influenza Vaccines" by people in Profiles.
-
Facial paralysis and vaccinations: a vaccine adverse event reporting system review. Fam Pract. 2022 01 19; 39(1):80-84.
-
SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire. Inflamm Bowel Dis. 2021 Oct 20; 27(11):1858-1861.
-
Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey. Inflamm Bowel Dis. 2021 10 20; 27(11):e134-e135.
-
Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store. JAMA. 2021 09 14; 326(10):899-900.
-
Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design. Brief Funct Genomics. 2021 09 11; 20(5):289-303.
-
Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Circulation. 2021 11 02; 144(18):1476-1484.
-
COVID-19 and the flu: data simulations and computational modelling to guide public health strategies. Fam Pract. 2021 Aug 27; 38(Suppl 1):i16-i22.
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season. MMWR Recomm Rep. 2021 08 27; 70(5):1-28.
-
COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey. Int J Environ Res Public Health. 2021 08 22; 18(16).
-
Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines. J Control Release. 2021 10 10; 338:201-210.